Roderick Young's Email & Phone

Roderick A. Young brings more than 20 years of executive experience in the medical device industry to CyberHeart. Mr. Young currently serves as a venture partner at Three Arch Partners, which he joined in May 2006. Other management roles held by Mr. Young during his career include founder, President and CEO of Vivant Medical Inc., a Three Arch Partners medical device company focused on microwave ablation that was acquired by Tyco International Ltd. (now part of Covidien). He also was President and CEO of Targesome Inc., a biopharmaceutical company developing receptor-targeted agents to treat and diagnose cancer and other diseases, and CEO of Focus Surgery Inc., a pioneer in the development and commercialization of products using high intensity focused ultrasound. During his career Mr. Young was Chairman, CEO of General Surgical Innovations Inc. (GSI), an emerging technology company funded by Three Arch Partners that developed the balloon dissection product line which was important to the growth of laparoscopic hernia repair. After successfully growing the organization, he led GSI through an initial public offering and acquisition by United States Surgical Corporation (now part of Covidien AG). He also was President of Toshiba America MRI Inc., President and COO of Diasonics, and Chief Financial Officer of Raychem. Young received a Bachelor of Science degree in Industrial Engineering from Stanford University and a Master's Degree in Business Administration from The Harvard Business School.